ESMO Breast Cancer 2019: Making the Case for Integrated Care Ahead of Innovation
Therapeutic innovations should go hand in hand with a multidisciplinary, fully integrated approach to patient care is the reminder issued by Prof Giuseppe Curigliano
ESMO Media Releases
Global HER2 Testing Survey Raises Questions About Priorities for Breast Cancer Resources
A global survey of HER2 testing has raised questions about how resources should be spent on potentially lifesaving HER2 targeted therapies for breast cancer
Continuous Chemotherapy Improves Outcomes and Quality of Life in Advanced Breast Cancer
Continuous chemotherapy shows greater benefit in patients with advanced breast cancer
Innovation at the heart of breast cancer care: First ESMO Breast Cancer Congress
Innovative breast cancer treatment will be discussed during the first ESMO Breast Cancer Congress in Berlin
Maintenance immunotherapy fails to improve survival in extensive small cell lung cancer
Maintenance immunotherapy fails to improve survival in extensive-stage small cell lung cancer (SCLC), according to late-breaking results from the CheckMate 451 study to be presented today at the European Lung Cancer Congress 2019.
Studies give new insights on immunotherapy in elderly patients with advanced NSCLC
Two studies to be reported at ELCC 2019 provide new insights on the efficacy and safety of immunotherapy in elderly patients with advanced non-small-cell lung cancer (NSCLC)
ESMO Drives EU-level Action to Tackle Shortages of Essential Medicines
Shortages of essential cancer medicines have a direct impact on patient care across Europe.
Jonas Bergh Receives First ESMO Breast Cancer Award
The newly established 2019 ESMO Breast Cancer Award will be delivered in connection with the inaugural ESMO Breast Cancer Congress
European Lung Cancer Congress 2019: A Multidisciplinary Approach to Fight Lung Cancer
Participants from across the world will meet in Geneva to learn about and discuss the latest research in the field of lung cancer.
Researchers Develop New Method to Detect Cancerous DNA in Lung Cancer Patients’ Blood: An Advance in Liquid Biopsies
A new method of determining the sequence of molecules in DNA can be used to detect small fragments of cancerous genetic material in blood samples from lung cancer patients with a high degree of accuracy.
Françoise Mornex is First Female Recipient of Heine H. Hansen Award
Françoise Mornex is first female recipient of Heine H. Hansen Award
Rare Cancers a Growing Focus of Early-stage Clinical Trials
The proportion of early-stage drug trials tackling the biggest cancer killers has declined sharply since the early 1990s as less common tumour types receive increasing attention, according to new research to be presented during the International Congress on Targeted Anticancer Therapies (TAT) 2019